Not COVID-19, Don't Overlook Pneumocystis in Patients on Gefitinib!
| Affiliation auteurs | !!!! Error affiliation !!!! |
| Titre | Not COVID-19, Don't Overlook Pneumocystis in Patients on Gefitinib! |
| Type de publication | Journal Article |
| Year of Publication | 2021 |
| Auteurs | Barben J, Quipourt V, Vovelle J, Putot A, Manckoundia P |
| Journal | CURRENT ONCOLOGY |
| Volume | 28 |
| Pagination | 961-964 |
| Date Published | FEB |
| Type of Article | Article |
| ISSN | 1198-0052 |
| Mots-clés | COVID-19, gefitinib, pneumocystis jirovecii, tyrosine-kinase inhibitor |
| Résumé | An 82-year-old woman treated for advanced lung cancer with gefitinb was admitted to the emergency unit complaining of dyspnea. Chest computed tomography found abnormalities classified as possible diffuse COVID-19 pneumonia. RT-PCR for Sars-Cov-2 was twice negative. PCR for Pneumocystis jirovecii was positive on bronchoalveolar lavage. The final diagnosis was Pneumocystis jirovecii pneumonia. Therefore, physicians must be careful not to misdiagnose COVID-19, especially in cancer patients on small-molecule therapeutics like gefitinib and corticosteroids. |
| DOI | 10.3390/curroncol28010094 |